Combination comprising paclitaxel for treating ovarian cancer

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/506 (2006.01) A61P 35/00 (2006.01) A61K 31/337 (2006.01)

Patent

CA 2714608

The invention relates to the combination of an endothelin receptor antagonist of formula (I) with paclitaxel, and in particular to this combination for therapeutic use, simultaneously, separately or over a period of time, in the treatment of ovarian cancer.

L'invention concerne une combinaison d'un antagoniste récepteur d'endothéline de formule (I) avec du paclitaxel, et plus particulièrement, cette combinaison à usage thérapeutique, simultanément, séparément ou durant une certaine période, dans le traitement du cancer des ovaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination comprising paclitaxel for treating ovarian cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination comprising paclitaxel for treating ovarian cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination comprising paclitaxel for treating ovarian cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1501215

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.